Luis Diaz
Director/Board Member at QUEST DIAGNOSTICS INCORPORATED
Net worth: 185 390 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James Davis | M | 61 | 11 years | |
| Victor Velculescu | M | - |
Personal Genome Diagnostics, Inc.
 Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | 14 years |
| Megan Bailey | F | - |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | 6 years |
| Denise Morrison | F | 70 | 5 years | |
| Eric Laub | M | - | 3 years | |
| Lily Li | M | - |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Michael Deppe | M | 59 | 26 years | |
| Jacquelyn Sandell | F | - | 5 years | |
| Kavita Patel | M | 50 |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Wright Lassiter | M | 60 | 4 years | |
| James T. LaFrance | M | 65 |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | 7 years |
| Catherine Doherty | F | 61 | 34 years | |
| Tracey Doi | F | 63 | 3 years | |
| Timothy Ring | M | 66 | 13 years | |
| Vicky Gregg | F | 69 | 10 years | |
| Gary Pfeiffer | M | 74 | 20 years | |
| Timothy Main | M | 66 | 10 years | |
| Michael Prevoznik | M | 62 | 25 years | |
| Peter Klein | M | 46 |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Dermot Victor Shorten | M | - | 16 years | |
| Patrick Plewman | M | 58 | - | |
| Sean Mersten | M | - | - | |
| Kristin Wallace | F | - | - | |
| Mark Delaney | M | - | 2 years | |
| Maura Kadan | F | - |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Bert Vogelstein | M | - |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Sam Samad | M | 54 | 2 years | |
| Dennis Moynihan | M | - | - | |
| Stephen Milner | M | - |
The Johns Hopkins University School of Medicine
| 19 years |
| Shawn Bevec | M | - | - | |
| Alyssa Waxenberg | F | 53 | 3 years | |
| Doug Lang | M | - | 11 years | |
| Cecilia K. McKenney | F | 61 | 6 years | |
| Tracy L. Cinco-Abela | F | - | 17 years | |
| Gary D. Samuels | M | - | 28 years | |
| Peter Pronovost | M | 59 |
The Johns Hopkins University School of Medicine
| 13 years |
| Yuri Fesko | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Cary Pfeffer | M | 61 | 8 years | |
| Kimberlee Drapkin | F | 55 | 10 years | |
| Perry Karsen | M | 69 | 7 years | |
| Richard Murray | M | 65 | 9 years | |
| Malin Deon | F | - | - | |
| Sam Small | M | - |
The Johns Hopkins University School of Medicine
| 6 years |
| Robert Iannone | M | 57 | 3 years | |
| Garry Nicholson | M | 69 |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Hugh Cole | M | 59 | 6 years | |
| Anna L. Barry | M | - | 5 years | |
| Gail Wilensky | M | 80 | 27 years | |
| Barbara Duncan | F | 59 | 7 years | |
| John Duncan Higgons | M | 69 | 7 years | |
| Jigar Raythatha | M | 47 | 2 years | |
| Robert Kamen | M | 79 | 10 years | |
| Mary Margaret Huizinga | M | 47 |
The Johns Hopkins University School of Medicine
| - |
| Haley Laken | M | - | - | |
| Dmitri Wiederschain | M | - | - | |
| Min Li | M | 62 |
The Johns Hopkins University School of Medicine
| 20 years |
| Lauren Lee | M | - |
The Johns Hopkins University School of Medicine
| 4 years |
| Jamie Platt | M | - |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Luisa Salter-Cid | M | 60 | 2 years | |
| Emma Lees | M | - | 1 years | |
| Deborah Law | M | - | 3 years | |
| Douglas Ward | M | - |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | 4 years |
| Benjamin Carson | M | 73 |
The Johns Hopkins University School of Medicine
| 29 years |
| Antony Newton | M | - |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Tai-Li Chang | M | - |
The Johns Hopkins University School of Medicine
| 4 years |
| Jay Wohlgemuth | M | - | 7 years | |
| Jonathan M. Ellen | M | - |
The Johns Hopkins University School of Medicine
| 11 years |
| Le Fei Sun | M | 44 |
The Johns Hopkins University School of Medicine
| 1 years |
| Elizabeth G. Trehu | M | 64 | 8 years | |
| Gabrielle Wolfson | F | - | 5 years | |
| Douglas Kerr | M | 57 |
The Johns Hopkins University School of Medicine
| 11 years |
| Blake Scott | M | - |
The Johns Hopkins University School of Medicine
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 72 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Luis Diaz
- Personal Network
